Your browser doesn't support javascript.
loading
Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto, A; Sameshima, Y; Yokoyama, S; Terashima, Y; Sugimura, T; Terada, M; Yokota, J.
Affiliation
  • Okamoto A; National Cancer Center Research Institute, Tokyo, Japan.
Cancer Res ; 51(19): 5171-6, 1991 Oct 01.
Article in En | MEDLINE | ID: mdl-1680546
ABSTRACT
The p53 gene on chromosome 17p is considered to be a tumor suppressor gene, and frequent mutations of the p53 gene have been found in a wide variety of human cancers. We examined 31 ovarian cancers for allelic losses and mutations of the p53 gene by polymerase chain reaction-single strand conformation polymorphism analysis as well as restriction fragment length polymorphism analysis. Allelic loss of the p53 gene was detected in 16 of 20 cases (80%). Mutations were detected in 9 of 31 cases (29%) 2 cases in exon 4; 5 cases in exons 5-6; and 2 cases in exons 7-8. In 8 of 9 cases, p53 mutations were accompanied by losses of the normal allele. These alterations of the p53 gene were commonly detected from stage I to stage IV. These results suggest that alterations of the p53 gene play an important role in the development of human ovarian cancers.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Ovarian Neoplasms / Chromosomes, Human, Pair 17 / Genes, p53 / Mutation Limits: Female / Humans Language: En Journal: Cancer Res Year: 1991 Type: Article Affiliation country: Japan
Search on Google
Database: MEDLINE Main subject: Ovarian Neoplasms / Chromosomes, Human, Pair 17 / Genes, p53 / Mutation Limits: Female / Humans Language: En Journal: Cancer Res Year: 1991 Type: Article Affiliation country: Japan